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Hans Holbein the Younger (1498 - 1542) was one of the luminaries of 16th century portraiture. 
He depicted major political and intellectual figures of the Renaissance and was appointed official 
court painter by King Henry VIII in 1536, a year during which he painted the portrait of Sir 
Richard Southwell (1504-1564). This portrait now belongs to the Galleria degli Uffizi in Florence, 
while a preliminary drawing of the same image is owned by Queen Elizabeth II. (see image left)
Richard Southwell was a scion of landed gentry who served in the office of Thomas Cromwell, 
Chief Minister to Henry VIII and proponent of the emerging doctrine of royal supremacy 
over the church. From 1535 onwards, Southwell took an active part in the Crown’s efforts to 
expropriate the property of religious orders that had been dissolved in the aftermath of the break 
with the Roman Catholic Church. The proximate reason for the dissolution of the monasteries 
in England was to eradicate alleged religious corruption; however, the ultimate purpose was to 
secure Henry VIII’s absolute power as supreme head of Church as well as State. Accounts from 
that time suggest that Southwell profited handsomely from these policies. 
In the portrait, the two scars that Holbein depicted on Southwell’s neck are strikingly similar in 
appearance and location to those resulting from mycobacterial infection of the cervicofacial lymph 
nodes (scrofula). The extent to which the wound appears to have healed suggests that Southwell 
may have suffered such an infection at least several years before posing for this painting, or 
perhaps even in childhood. The marks had long been misinterpreted as blemishes on the painting 
itself, until the preliminary drawing was lifted from its backing sheet in the late 1970s, revealing 
the depiction of the scars and confirming that Holbein had intentionally painted them. 
Scrofula, or mycobacterial lymphadenitis, was often termed ‘the King’s Evil’. Medical wisdom in 
those times contended that sufferers of this kind of lymphadenitis could be cured by the physical 
touch of a monarch. This practice survived in England into the early 18th century, as the frequent 
self-resorption of the infection misled people into believing in the efficacy of the “treatment”. 
Was Southwell cured by “the Kings touch” and could he be deliberately showcasing his scars in 
gratitude to Henry VIII? 
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